A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of NST-4016 in Patients With Nonalcoholic Steatohepatitis (NASH)

Clinical Trial

Study Status:

Contact Information:

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose

The primary objective of this study is to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis. The secondary objective is to determine the safety and tolerability of NST-4016 in patients with NASH.

Information

Principal Investigator	Sriramachandra Badiga, MD
Co-PI
Sponsor
Type of Trial	Prospective/Interventional

Ask

We are here to help. If you have any question about your participation in a clinical trial, please contact us.

Participate

To participate in existing clinical trials, please contact us